B-lactoglobulin-Modified Mesoporous Silica Nanoparticles, A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells
Viewed:
1071
Fenbendazole, which is an anthelmintic, was encapsulated into succinylated beta-lactoglobulin-modified, amine-functionalised mesoporous silica nanoparticles to protect the drug throughout gastrointestinal tract and improve its anticancer effects against prostate cancer.
The data resulting from this study include the Higuchi kinetic model of the drug release and the toxicity effects of the prepared formulations against HEK-293 cells.
Geographical area of data collection
kmlPolyCoords
153.317870,-26.996845 152.668523,-26.996845 152.668523,-27.767441 153.317870,-27.767441 153.317870,-26.996845
Publications
Esfahani, Maedeh Koohi Moftakhari, Alavi, Seyed Ebrahim, Cabot, Peter J., Islam, Nazrul, & Izake, Emad L. (2022) B-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells. Pharmaceutics, 14(4), Article number: 884.
https://eprints.qut.edu.au/229955/
Research areas
Biomaterials
Biotechnology
Nanotechnology
Cite this collection
Koohi Moftakhari Esfahani, Maedeh; Alavi, Seyedebrahim; J. Cabot, Peter; Islam, Nazrul; L. Izake, Emad; (2022): B-lactoglobulin-Modified Mesoporous Silica Nanoparticles, A Promising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells. Queensland University of Technology. (Dataset) https://doi.org/10.25912/RDF_1660607767379
Access the data
Data file types
Adobe Acrobat (.pdf)
Licence
Copyright
© Maedeh Koohi Moftakhari Esfahani, 2022.
Dates of data collection
From 2020-07-01 to 2022-03-30
Connections
Has association with
Contacts
Name: Mrs Maedeh Koohi Moftakhari Esfahani
Email: maedeh.koohi@hdr.qut.edu.au
Other
Date record created:
2022-07-23T20:44:15
Date record modified:
2022-08-16T11:15:52
Record status:
Published - Open Access